The combined analysis of microbiome, immunological parameters and host genetics in patients has potential for applying personalized approaches of prevention, diagnostics or therapy in the future. However, the acquisition and analysis of these patient characteristics in a scientifically sound, technically reliable, cost-effective, practicable and future-oriented fashion are a far from trivial task. Therefore the objectives of the study are (i) to optimize a sample and data acquisition and analysis pipeline that fulfills these criteria (using samples from healthy volunteers); (ii) validate the pipeline in a cohort of children undergoing stem cell transplantation, yielding information on host immuno-genetics, gut immune function and the human gut microbiome; (iii) deduct the most critical parameters for host-microbiome interplay from this complex dataset.
Study Type
OBSERVATIONAL
Enrollment
60
Intervention is not conducted as part of the study but patients at Tübingen University Hospital undergoing this intervention as part of their standard care are being monitored in this observational study.
University Children's Hospital Tübingen
Tübingen, Germany
RECRUITINGImmune system - intestinal microbiota co-re-emergence after myeloablative conditioning and antibiotics treatment, respectively.
Time frame: through study completion, anticipated after 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.